Location: Geneva Contract Type: full – time, permanent employment Travel requirements: up to 15% of working time
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
For more information, please see our website, https://medicinespatentpool.org/
The Business Development in-Licensing Manager is a key member of the Business Development team, who will directly assist the Business Development Director in meeting the strategic, scientific, therapeutic, and commercial needs of MPP. The role contributes to shaping MPP business development strategy through the in-licensing of target pharmaceutical assets and associated development & manufacturing technologies.
Competitive Analysis and Opportunities Assessment
Business Development and Deal Structuring
Cross-functional Collaboration and Due Diligence
External Engagement and Representation
Essential
Desirable
MPP’s richness lies in its staff: a small dynamic and multicultural team.
To flourish in our team, you should identify with our values of Respect, Courage, Generosity, and Commitment.
Moreover, as the Business Development in-Licensing Manager you will also demonstrate:
At the Medicines Patent Pool (MPP), you will join a mission-driven, international organisation working to improving access to life-saving medicines and technologies worldwide.
As part of our team, you will benefit from supportive and flexible working environment, along with a competitive non-profit compensation and benefits package, including generous paid time off, flexible working arrangements, comprehensive social security and insurance coverage, a monthly contribution toward health insurance, public transport or parking and relocation support for eligible international recruits. Clear objectives, regular performance reviews, continuous learning, and employee well-being are central to how we work and grow together.
We respect all individuals regardless of race, gender, ethnicity, sexual orientation, religion, HIV status or disability. All qualified applications are welcome.
If you recognise yourself in this description and wish to join our outstanding team, please send a cover letter and C.V. to recruitment@medicinespatentpool.org including “BD M-in-Licensing” as reference in the subject line by 20 February 2026.
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.